Representatives of the pharmaceutical industry discussed issues of concern with the Chairman of the Medfarmcontrol Committee
The Committee of Medical and Pharmaceutical Control of the Ministry of Health of the Republic of Kazakhstan held a meeting with representatives of the pharmaceutical industry. The meeting was held under the leadership of the Chairman of the KM and FC of the Ministry of Health of the Republic of Kazakhstan Bauyrzhan Baiserkin.
The meeting was attended by the first heads of pharmaceutical associations, Chairman of the Board of SC Pharmacy LLP, CEO of NCELS and MI, Chairman of the Board of the National Center for Independent Examination, as well as representatives of structural divisions of the Ministry of Health of the Republic of Kazakhstan
During the meeting, issues of the introduction of mandatory labeling and traceability of medicines were raised. In addition, the issue of issuing indefinite registration certificates for medicines and medical products was discussed. Special attention was also paid to the certification of pharmaceutical specialists.
It should be noted that the certification will ensure the high quality and safety of the services provided in the pharmaceutical market. In turn, the Committee is open to suggestions from pharmaceutical associations and is ready to openly discuss all issues of concern. To this end, such meetings with representatives of the pharmaceutical industry will be held on a regular basis. Details of the decisions taken will be available on the official sources of the Committee.
The meeting was attended by the first heads of pharmaceutical associations, Chairman of the Board of SC Pharmacy LLP, CEO of NCELS and MI, Chairman of the Board of the National Center for Independent Examination, as well as representatives of structural divisions of the Ministry of Health of the Republic of Kazakhstan
During the meeting, issues of the introduction of mandatory labeling and traceability of medicines were raised. In addition, the issue of issuing indefinite registration certificates for medicines and medical products was discussed. Special attention was also paid to the certification of pharmaceutical specialists.
It should be noted that the certification will ensure the high quality and safety of the services provided in the pharmaceutical market. In turn, the Committee is open to suggestions from pharmaceutical associations and is ready to openly discuss all issues of concern. To this end, such meetings with representatives of the pharmaceutical industry will be held on a regular basis. Details of the decisions taken will be available on the official sources of the Committee.